Technical information
Manufacturer
NOVARTIS PHARMA S.A.S
Presentation
MENOREST 25 µg/24 h, dispositifs transdermiques
Boîte de 8 - (Code CIP : 350 134-6)
MENOREST 37,5 µg/24 h, dispositifs transdermiques
Boîte de 8 - (Code CIP : 338 247-9)
MENOREST 50 µg/24 h, dispositifs transdermiques
Boîte de 8 - (Code CIP : 338 239-6)
MENOREST 75 µg/24 h, dispositifs transdermiques
Boîte de 8 - (Code CIP : 338 241-0)
MENOREST 100 µg/24 h, dispositifs transdermiques
Boîte de 8 - (Code CIP : 338 243-3)
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
tuJ9dPmnrNnKdH8r